May 30, 2025

Explainable artificial intelligence increases the accuracy and endurance of dermatologists in melanoma diagnosis

Explainable artificial intelligence increases the accuracy and endurance of dermatologists in melanoma diagnosis

Scientists at the German Cancer Research Center (DKFZ) have shown in an international eye-tracking study that dermatologists not only improve their diagnostic accuracy by using explainable artificial intelligence, but also show significantly less fatigue when assessing challenging cases. The researchers were able to demonstrate this by measuring a reduction in cognitive stress indicators.

Bastian Schilling, Director at the Dermatology Clinic of Frankfurt University, was one of the dermatologists participating in the current study.
(C) private

In a two-phase study, 76 dermatologists each assessed 16 images (melanomas and benign moles, known as nevi) taken with a dermatoscope, an illuminated magnifying glass, first using standard AI and then with an explainable AI solution. Explainable AI, or XAI for short, combines AI predictions with textual and image-based explanations based on established dermatoscopic features. Eye-tracking measurements were used to record how long and how intensively the participants looked at certain image regions and explanations.

Eye tracking as an objectification method

Analysis of gaze patterns showed that difficult cases were associated with an increased number of fixations – an objective indicator of cognitive effort. In the XAI phase, this effort decreased in challenging cases compared to standard AI, indicating a relieving effect of the explanations provided.

“Our results show that explainable AI not only increases diagnostic confidence, but can also support endurance in difficult cases in clinical practice,” explains Titus J. Brinker, senior author of the current study. “Especially with a high caseload and complex lesions, explainable artificial intelligence can help prevent fatigue and thus minimize potential sources of error.”

Follow-up studies are planned to investigate the long-term impact on workload and diagnostic quality in real-world clinical settings.


Chanda, T., Haggenmueller, S., Bucher, TC. et al. Dermatologist-like explainable AI enhances melanoma diagnosis accuracy: eye-tracking study.
Nature Communications, 2025, https://doi.org/10.1038/s41467-025-59532-5

Our latest News

discover more
Study shows how lymph node architecture affects cancer growth

Study shows how lymph node architecture affects cancer growth

A new study maps the organisation of immune and stromal cells in lymph nodes and shows how loss of this organisation affects prognosis in certain lymphomas Summary Researchers from EMBL Heidelberg, Heinrich Heine University Düsseldorf (HHU), and Düsseldorf University Hospital (UKD) have succeeded for the first time in mapping the organisation of immune and stromal […]

High-throughput testing of drugs on mini-tumors reveals vulnerabilities in meningiomas

High-throughput testing of drugs on mini-tumors reveals vulnerabilities in meningiomas

Meningiomas are the most common brain tumors. Until now, only two methods have generally been considered for treating them: surgery and radiation therapy. A research team in Heidelberg has now developed a potential new approach for effective systemic therapy. Its members from Heidelberg University’s Faculty of Medicine and Heidelberg University Hospital (UKHD) tested the effectiveness […]

Development of a method for improved monitoring of the early stages of bone marrow cancer

Development of a method for improved monitoring of the early stages of bone marrow cancer

An international team, including researchers from Heidelberg University’s Faculty of Medicine and Heidelberg University Hospital, has developed the PANGEA-SMM prognostic tool. This tool makes it possible to determine with greater accuracy than before whether a precancerous condition—known as “smoldering multiple myeloma”—is progressing and thus requires treatment. The free online tool for treatment teams is available […]

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp